Fernando Gaion

The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer

Giuseppe Toffoli, Erika Cecchin, Giuseppe Corona et al. · Journal of Clinical Oncology · 2006 · 333 citations · Full text

Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial

Dino Amadori, Massimo Aglietta, Barbara Alessi et al. · The Lancet Oncology · 2013 · 196 citations

Medicine, Cancer Management, Clinical Trials +9

A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma

Gerardo Rosati, G. Ambrosini, Sandro Barni et al. · Annals of Oncology · 2015 · 131 citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Cancer Screening +10

Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II)

Milvia Zambetti, Mauro Mansutti, Patricia Gómez et al. · Breast Cancer Research and Treatment · 2011 · 52 citations

Surgical Oncology, Breast Oncology, Adaptive Study Design +11

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations

Breast Oncology, Medicine, Primary Analysis +7